Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

Adelaide de Mauleon; Sandrine Sourdet; Anna Renom-Guiteras; Sophie Gillette-Guyonnet; Helena Leino-Kilpi; Staffan Karlsson; Michel Bleijlevens; Adela Zabategui; Kai Saks; Bruno Vellas; David Jolley; Maria Soto

doi:10.1016/j.jamda.2014.06.015

Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

Adelaide de Mauleon, Sandrine Sourdet, Anna Renom-Guiteras, Sophie Gillette-Guyonnet, Helena Leino-Kilpi, Staffan Karlsson, Michel Bleijlevens, Adela Zabategui, Kai Saks, Bruno Vellas, David Jolley, Maria Soto

Research output: Contribution to journal › Article › peer-review

Abstract

To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.

Original language	English
Pages (from-to)	812-818
Journal	Journal of the American Medical Directors Association
Volume	15
Issue number	11
DOIs	https://doi.org/10.1016/j.jamda.2014.06.015
Publication status	Published - 2014

Subject classification (UKÄ)

Health Care Service and Management, Health Policy and Services and Health Economy

Access to Document

10.1016/j.jamda.2014.06.015

http://www.ncbi.nlm.nih.gov/pubmed/25129474?dopt=Abstract

Cite this

de Mauleon, A., Sourdet, S., Renom-Guiteras, A., Gillette-Guyonnet, S., Leino-Kilpi, H., Karlsson, S., Bleijlevens, M., Zabategui, A., Saks, K., Vellas, B., Jolley, D., & Soto, M. (2014). Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study. Journal of the American Medical Directors Association, 15(11), 812-818. https://doi.org/10.1016/j.jamda.2014.06.015

@article{a9de2141d69e4898b3d94f23711b7f6d,

title = "Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.",

abstract = "To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.",

author = "{de Mauleon}, Adelaide and Sandrine Sourdet and Anna Renom-Guiteras and Sophie Gillette-Guyonnet and Helena Leino-Kilpi and Staffan Karlsson and Michel Bleijlevens and Adela Zabategui and Kai Saks and Bruno Vellas and David Jolley and Maria Soto",

year = "2014",

doi = "10.1016/j.jamda.2014.06.015",

language = "English",

volume = "15",

pages = "812--818",

journal = "Journal of the American Medical Directors Association",

issn = "1525-8610",

publisher = "Elsevier",

number = "11",

}

de Mauleon, A, Sourdet, S, Renom-Guiteras, A, Gillette-Guyonnet, S, Leino-Kilpi, H, Karlsson, S, Bleijlevens, M, Zabategui, A, Saks, K, Vellas, B, Jolley, D & Soto, M 2014, 'Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.', Journal of the American Medical Directors Association, vol. 15, no. 11, pp. 812-818. https://doi.org/10.1016/j.jamda.2014.06.015

Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study. / de Mauleon, Adelaide; Sourdet, Sandrine; Renom-Guiteras, Anna et al.

In: Journal of the American Medical Directors Association, Vol. 15, No. 11, 2014, p. 812-818.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

AU - de Mauleon, Adelaide

AU - Sourdet, Sandrine

AU - Renom-Guiteras, Anna

AU - Gillette-Guyonnet, Sophie

AU - Leino-Kilpi, Helena

AU - Karlsson, Staffan

AU - Bleijlevens, Michel

AU - Zabategui, Adela

AU - Saks, Kai

AU - Vellas, Bruno

AU - Jolley, David

AU - Soto, Maria

PY - 2014

Y1 - 2014

N2 - To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.

AB - To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.

U2 - 10.1016/j.jamda.2014.06.015

DO - 10.1016/j.jamda.2014.06.015

M3 - Article

C2 - 25129474

VL - 15

SP - 812

EP - 818

JO - Journal of the American Medical Directors Association

JF - Journal of the American Medical Directors Association

SN - 1525-8610

IS - 11

ER -

Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Cite this